Recruiting Polycystic Kidney Disease Studies in Ann Arbor
A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)
To evaluate the safety of tolvaptan in pediatric subjects with ARPKD...
A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
The primary objective of this study is to evaluate the effect of tolvaptan on the need for renal replacement therapy in pediatric subjects with autosomal recessive polycystic kidney disease (ARPKD)...
About Polycystic Kidney Disease Clinical Trials in Ann Arbor
Polycystic kidney disease (PKD) is a genetic disorder causing numerous fluid-filled cysts to grow in the kidneys, leading to kidney enlargement and progressive loss of function. Autosomal dominant PKD is the most common form. Treatment includes tolvaptan and management of complications.
There are currently 2 polycystic kidney disease clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 40 participants. Research is being sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Polycystic Kidney Disease Clinical Trials in Ann Arbor — FAQ
Are there polycystic kidney disease clinical trials in Ann Arbor?
Yes, there are 2 polycystic kidney disease clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What polycystic kidney disease treatments are being tested?
The 2 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for polycystic kidney disease.
Data updated March 2, 2026 from ClinicalTrials.gov